Gross Margin
23.97%vs Specialty Chemicals peers Updated Jul 19, 2026Profit Margin
7.60%vs Specialty Chemicals peers Updated Jul 19, 2026Operating Margin
12.34%vs Specialty Chemicals peers Updated Jul 19, 2026Return on Assets (TTM)
5.30%vs Specialty Chemicals peers Updated Jul 19, 2026Return on Equity (TTM)
9.79%vs Specialty Chemicals peers Updated Jul 19, 2026Revenue (TTM)
2.13BUSDUpdated Jul 19, 2026Revenue per Share (TTM)
68.25USDUpdated Jul 19, 2026Quarterly Revenue Growth
11.20%vs Specialty Chemicals peers Updated Jul 19, 2026Gross Profit (TTM)
529.50MUSDUpdated Jul 19, 2026EBITDA (TTM)
379.60MUSDUpdated Jul 19, 2026Net Income (TTM)
161.80MUSDUpdated Jul 19, 2026Quarterly Earnings Growth (YoY)
11.20%vs Specialty Chemicals peers Updated Jul 19, 2026Operating Cash Flow (TTM)
230.20MUSDUpdated Jul 19, 2026Levered Free Cash Flow (TTM)
85.25MUSDUpdated Jul 19, 2026Forward Annual Dividend Rate
0.4800USDUpdated Jul 19, 2026Forward Annual Dividend Yield
0.64%Updated Jul 19, 2026Trailing Annual Dividend Rate
0.4700USDUpdated Jul 19, 2026Trailing Annual Dividend Yield
0.63%Updated Jul 19, 20265-Year Average Dividend Yield
0.45%Updated Jul 19, 2026Payout Ratio
9.04%vs Specialty Chemicals peers Updated Jul 19, 2026Minority Interest (Equity)
36.30MUSDFY2025 · Dec 31, 2025Revenue
2.07BUSDFY2025 · Dec 31, 2025Cost of Goods Sold
1.55BUSDFY2025 · Dec 31, 2025Gross Profit
518.00MUSDFY2025 · Dec 31, 2025Operating Income
287.10MUSDFY2025 · Dec 31, 2025Pre-tax Income
-14.00MUSDFY2025 · Dec 31, 2025Income Tax Expense
4.90MUSDFY2025 · Dec 31, 2025Net Income
-14.00MUSDFY2025 · Dec 31, 2025EBIT
40.50MUSDFY2025 · Dec 31, 2025EBITDA (Income Statement)
371.40MUSDFY2025 · Dec 31, 2025Research & Development
22.90MUSDFY2025 · Dec 31, 2025Selling, General & Administrative
208.00MUSDFY2025 · Dec 31, 2025Non-operating Interest Expense
54.50MUSDFY2025 · Dec 31, 2025EPS (Basic)
-0.5900USDFY2025 · Dec 31, 2025EPS (Diluted)
-0.5900USDFY2025 · Dec 31, 2025Basic Shares Outstanding
31.40MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
31.40MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
-14.00MUSDFY2025 · Dec 31, 2025Minority Interests (P&L)
-4.40MUSDFY2025 · Dec 31, 2025Operating Cash Flow
32.60MUSDFY2025 · Dec 31, 2025Free Cash Flow
-74.50MUSDFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
329.00MUSDFY2025 · Dec 31, 2025Starting Profit (CF Statement)
-14.00MUSDFY2025 · Dec 31, 2025Depreciation & Amortization
91.20MUSDFY2025 · Dec 31, 2025Deferred Taxes (CF)
-45.80MUSDFY2025 · Dec 31, 2025Stock-based Compensation
11.90MUSDFY2025 · Dec 31, 2025Other Non-cash Items
10.10MUSDFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
-5.20MUSDFY2025 · Dec 31, 2025Change in Accounts Payable (CF)
-2.20MUSDFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
-13.40MUSDFY2025 · Dec 31, 2025Capital Expenditures
-107.10MUSDFY2025 · Dec 31, 2025Net Acquisitions
0.00USDFY2025 · Dec 31, 2025Purchase of Investments
-14.30MUSDFY2025 · Dec 31, 2025Sale of Investments
15.30MUSDFY2025 · Dec 31, 2025Other Investing Activity
-16.70MUSDFY2025 · Dec 31, 2025Net Investing Cash Flow
-122.80MUSDFY2025 · Dec 31, 2025Long-term Debt Issuance
0.00USDFY2025 · Dec 31, 2025Long-term Debt Payments
-11.40MUSDFY2025 · Dec 31, 2025Net Short-term Debt Issuance
-4.80MUSDFY2025 · Dec 31, 2025Common Stock Repurchase
-58.50MUSDFY2025 · Dec 31, 2025Common Dividends Paid
-14.20MUSDFY2025 · Dec 31, 2025Other Financing Charges
-7.60MUSDFY2025 · Dec 31, 2025Net Financing Cash Flow
-96.50MUSDFY2025 · Dec 31, 2025